Innovationen für die Medizin

Logo Forum MedTech Pharma Logo VDE|DGBMT

Medical Device Directives - Pharmaceutical Regulation
Which one applies to my new idea?

7. September 2009
10.30 - 17.30
ICM Munich

This course is one out of seven continuing education courses at the World Congress 2009 organised by the VDE|DGBMT and the Forum MedTechPharma.

We look forward to seeing you in Munich.

Link to the registration

Link to the course overview

Program "From Science to Innovation" (pdf)


Course Instructors

Ulrich M. Gassner, Prof.

  • Head of the Research Center for Medical Devices Law, University Augsburg
  • Studies, graduation and postdoctoral lecture qualification of the jurisprudence at the Universität Tübingen


Andrea Weiland-Waibel, Ph.D.

  • Managing Director of explicat pharma GmbH, Hohenbrunn
  • Member of AAPS, several other professional organisations based in Europe (e.g. APV), expert in medical device combination products
  • R&D projects, responsible for pharmaceutical development (Phase I -III, candidate characterization)
  • Study of pharmacy at the Ludwig-Maximilians-Universität Munich


Hans-Albert Schultz

  • Managing Director of MPC GMBH, Dobersdorf and Chairman of the board of MPC INTERNATIONAL S.A., Luxembourg, Luxembourg
  • Founder and owner of MPC SCHULTZ & PARTNER, a European consultancy for medical devices in regulatory, pharmaceutical and clinical area
  • Production Manager and Quality Control Manager at various pharmaceutical companies
  • Study of pharmacy at the Christian Albrecht Universität Kiel

Training Material

(Download for Participants only)
Ullrich M. Gassner: Medical Device Directives - Pharmaceutical Regulation (PDF 1 MB)
Andrea Weiland-Waibel: Combination Devices - Pharmaceutical Regulation Requirements (PDF 300 kB)
Hans-Albert Schultz: Medical Device Directives - Pharmaceutical Regulations (PDF 2.4 MB)


Medical Device Directives - Pharmaceutical Regulation - Which one applies to my new idea?

Medical products and pharmaceuticals must be approved before they may be sold in the European Union. Basically, the type of effect and intended use of such products or pharmaceuticals determine whether they are subject to the Medical Device Directive or the Pharmaceutical Regulation. However, such categorization isn't always that simple, since there are combination products or medical products that also contain an active pharmaceutical substance.

To help out in such situations, the course provides an overview of the European Directives on various categories of medical products and on the Pharmaceutical Regulation. The course offers aids for determining which Directive is relevant, explains the conformity assessment procedure and the pharmaceutical marketing authorization application, and introduces the participating institutions for medical devices and pharmaceuticals.

The course explains the differences between the conformity assessment procedure and the pharmaceutical marketing authorization application as well as the procedures necessary for a combination of a medical device and a medicinal product, or for medical devices incorporating a medicinal substance having an ancillary action. Questions regarding the special requirements of pharmaceutical guidelines for combination devices will be answered: What has to be taken into consideration in the development phase, during routine production, and during the marketing phase? What documentation is needed? The course also provides an overview of the quality management system ISO 13485 (medical devices) versus EU-GMP (pharmaceuticals).

The course addresses the importance of taking the approval process into account early in the development stage, and discusses typical timelines. Several case studies illustrate the theoretical information and participants can apply their new knowledge in specific examples.


Participants

The courses are specially tailored for the national and international public from research institutions and small and medium enterprises.
The Monday Courses will be held in the course of the World Congress 2009 on Monday September 7 from 10:30 am - 5:30 pm and comprise three sections of 105 minutes each. The course will be held in English.

Registration fee

150 € (members)
175 € (non-members)
Member is defined a person who is a member of DGBMT or Forum MedTech Pharma.

Registration fee includes courseware, lunch and drinks. Registration for the World Congress 2009 is not included.
Link to the registration